GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
T

Tatva Chintan Pharma Chem TATVA.NS · INR

Materials · NSE · 🇮🇳 India

Compare

1,668.30

+3.89%

Close of 9 Nov 2026, in INR

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in INR, from our data supplier.

FY2026

Revenue

₹5.06bn

FY2018FY2026

Net income

₹420.5m

FY2018FY2026

Free cash flow

−₹841.4m

FY2018FY2026

Shareholders' equity

₹7.82bn

FY2018FY2026

Income statement

Fiscal years

FY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018
Revenue₹5.06bn₹3.83bn₹3.43bn₹4.24bn₹4.34bn₹2.75bn₹2.63bn₹2.06bn₹1.36bn
Research and development—₹83.9m₹79.4m₹60.4m₹37.1m₹24.0m₹26.3m₹23.3m₹5.7m
Operating income₹598.6m₹90.6m₹501.0m₹584.7m₹1.96bn₹603.0m₹532.5m₹687.6m₹477.2m
Net income₹420.5m₹57.1m₹303.5m₹454.9m₹958.7m₹522.6m₹377.9m₹205.4m₹122.9m
Diluted earnings per share17.972.4413.2019.4543.2523.5818.818.785.25

Balance sheet

At each fiscal year end

FY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018
Total assets₹10.04bn₹8.36bn₹8.19bn₹7.60bn₹6.58bn₹3.15bn₹2.49bn₹1.88bn₹1.44bn
Cash and short-term investments₹87.9m₹117.0m₹456.7m₹412.2m₹638.2m₹53.2m₹101.6m₹151.0m₹91.0m
Total liabilities₹2.22bn₹974.3m₹816.4m₹2.44bn₹1.85bn₹1.49bn₹1.31bn₹1.08bn₹852.5m
Debt₹1.20bn₹363.9m₹142.7m₹1.70bn₹1.20bn₹902.5m₹906.9m₹771.5m₹561.5m
Shareholders' equity₹7.82bn₹7.39bn₹7.37bn₹5.15bn₹4.73bn₹1.66bn₹1.18bn₹797.0m₹591.1m
Shares outstanding23m23m23m23m22m22m20m23m23m

Cash flow

Fiscal years

FY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018
Cash from operations₹296.3m₹246.7m₹980.4m₹277.8m₹203.8m₹243.2m₹253.1m₹73.6m₹104.1m
Capital spending−₹1.14bn−₹762.7m−₹1.29bn−₹2.03bn−₹891.6m−₹209.7m−₹481.7m−₹97.9m−₹304.6m
Free cash flow−₹841.4m−₹516.0m−₹304.7m−₹1.75bn−₹687.8m₹33.5m−₹228.6m−₹24.3m−₹200.5m
Dividends paid−₹23.4m−₹46.8m−₹46.8m−₹44.3m−₹44.3m−₹40.2m−₹40.2m−₹40.2m−₹40.2m

Latest quarters

By quarter end

Jun 2026Mar 2026Dec 2025Sept 2025Jun 2025Mar 2025Dec 2024Sept 2024
Revenue₹1.67bn₹1.34bn₹1.31bn₹1.24bn₹1.17bn₹1.08bn₹859.0m₹834.9m
Operating income₹217.3m₹183.7m₹164.2m₹131.6m₹83.6m₹361.3m₹311.3m−₹12.3m
Net income₹159.8m₹103.2m₹151.7m₹99.2m₹66.5m₹10.3m₹1.4m−₹6.6m
Diluted earnings per share6.834.416.494.242.850.440.06-0.29
Cash from operations———₹133.0m————
Capital spending———−₹559.0m————
Free cash flow———−₹426.0m————
Total assets—₹10.04bn—₹9.08bn—₹8.36bn—₹8.07bn
Cash and short-term investments₹87.9m₹87.9m₹171.7m₹178.5m₹141.0m₹117.0m₹148.7m₹154.4m
Debt—₹1.20bn—₹830.1m—₹363.9m—₹152.3m
Shareholders' equity₹7.82bn₹7.82bn₹7.54bn₹7.54bn₹7.39bn₹7.39bn₹7.38bn₹7.38bn

Financial ratios

Data as of 23 Sept 2026

FY2026FY2025FY2024FY2023FY2022FY2021FY2020
Operating margin11.8%2.4%14.6%13.8%45.3%21.9%—
Net margin8.3%1.5%8.8%10.7%22.1%19.0%—
Return on equity5.4%0.8%4.1%8.8%20.3%31.5%—
Return on assets4.2%0.7%3.7%6.0%14.6%16.6%—
Free cash flow yield3.4%2.4%5.5%5.6%2.8%1.1%—
Revenue growth32.2%11.5%-19.0%-2.3%57.6%4.6%—
Earnings growth636.1%-81.2%-33.3%-52.6%83.4%38.3%—
Current ratio1.64x2.76x3.74x1.31x2.54x1.56x—
Debt to equity0.15x0.05x0.02x0.33x0.25x0.54x—
Equity ratio77.9%88.3%90.0%67.7%71.9%52.7%—
Interest coverage21.00x7.02x7.67x6.99x42.15x13.88x—
R&D as a share of sales—2.2%2.3%1.4%0.9%0.9%1.0%
Buybacks as a share of market value-0.1%-1.6%1.7%-5.5%-0.0%-10.3%—

Growth per year

Compound annual rate

3 years5 years10 years
Revenue6.1%12.9%—
Operating income0.8%-0.1%—
Net income-2.6%-4.3%—

Valuation history

At each fiscal year end

FY2026FY2025FY2024FY2023FY2022FY2021
Price to earnings95.0—67.182.549.8112.4
Price to sales7.98.25.98.911.021.3

Dividends and splits

Per share, in the currency the company pays

Paid for 4 years. Last went ex-dividend on 11 Sept 2026.

FY2027FY2026FY2025FY2024FY2023
Paid in the year2.001.002.002.002.00

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.